Emerging Treatments

Cannabis for treatment of Crohn’s or colitis

Want to learn more about medical cannabis for inflammatory bowel disease? Join us from anywhere you have internet access to learn from experts about medical cannabis for individuals living with Crohn's or colitis. This presentation will discuss the use of cannabis for intestinal disorders, gut inflammation, symptom management and what current research tells us about cannabis and IBD. Get your questions answered by the experts in this interactive live webinar! 

This event is free and suitable for individuals living with Crohn's or colitis, caregivers of people with Crohn's or colitis, health care providers or those who wish to gain additional information.

Can't join us on February 20th? Register for the webinar below and we will send you a link to the recording. ​

Click here to register for the webinar!

To learn more from experts about about medical cannabis as a treatment for IBD, read this article

Fecal transplantation

Fecal transplantation (also known as ‘stool transplant’, ‘human probiotic infusion’ and ‘stool enema’), is an experimental procedure of inserting stool from a healthy donor into a recipient to restore the normal microbiome (microorganisms that live in our body) in a recipient’s large bowel.

The procedure is beginning to show some promise in the treatment of ulcerative colitis in controlled clinical trials, one funded by Crohn’s and Colitis Canada. Research is ongoing in this area. There are potential known and unknown risks associated with experimental treatment of this nature.

Crohn’s and Colitis Canada understands the eagerness and impatience of some patients; however, we urge patients not to perform fecal transplantation themselves, or to accept a fecal transplant, outside of a research ethics board-approved clinical trial and to wait for scientific evidence as there are significant safety concerns including risk of serious infection. This is still a new area of study, the effects of this treatment are still being investigated and the longer-term effects of fecal transplants remain unknown.

Read our full position paper on Fecal Transplantation here. 

Watch the video below to learn more from experts in the field about the human microbiome and latest advancements in fecal matter transplant research for the treatment of ulcerative colitis. This presentation was part of the 2017 Gutsy Learning Series

Stem cell therapies

Stem cells may be able to help repair some of the damage caused by inflammation by ‘resetting’ the immune system – making new cells, inhibiting inflammation, stimulating tissue repair and dampening the immune response.

Currently, there are no Health Canada approved stem cell therapies for treating Crohn’s disease, but many research teams around the world are working to discover stem cell therapies for Crohn’s.

Visit the Canadian Stem Cell Foundation website for more information on research progress in this area.

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.

Other Areas of Interest